The PBAC recommended a new treatment for Spinal Muscular Atrophy at its March meeting, a deferral for Vertex's cystic fibrosis therapy, mixed outcomes for cancer therapies and one company has declared it will not proceed with a recommendation. …
Positive outcome for SMA but mixed results on cancer submissions
April 26, 2021 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Medicines Australia tells productivity inquiry PBS rules leave out economic benefits
November 16, 2026 - -
First official US count confirms the broad uptake of GLP-1s for weight management
November 16, 2026 - - Latest News -
Can the PBS afford another agreement on the same terms?
November 16, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 13 November
November 13, 2026 - - Podcast -
A year on, Sanofi now asks staff to explain how they used AI
November 13, 2026 - - Latest News -
There is no need for AI to automate the care out of healthcare, Cohn warns
November 13, 2026 - -
Cochlear's global government affairs chief is putting AI to work
November 13, 2026 - - Latest News